Geron (STU:GON) Buildings And Improvements : €0.0 Mil (As of Mar. 2025)

View and export this data going back to 1996. Start your Free Trial

What is Geron Buildings And Improvements?

Geron's quarterly buildings and improvements increased from Sep. 2024 (€0.0 Mil) to Dec. 2024 (€2.8 Mil) but then declined from Dec. 2024 (€2.8 Mil) to Mar. 2025 (€0.0 Mil).

Geron's annual buildings and improvements declined from Dec. 2022 (€3.9 Mil) to Dec. 2023 (€3.3 Mil) and declined from Dec. 2023 (€3.3 Mil) to Dec. 2024 (€2.8 Mil).

Geron Buildings And Improvements Historical Data

The historical data trend for Geron's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Geron Buildings And Improvements Chart

Geron Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buildings And Improvements

Get a 7-Day Free Trial

4.35

4.18

3.92

3.26

2.75

Geron Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Buildings And Improvements	Get a 7-Day Free Trial															-	-	-	2.75	-

Geron Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Geron Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Geron Corp (STU:GON) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

GERN:USA 0IV3:UK GON:Germany

Address

919 East Hillsdale Boulevard, Suite 250, Foster City, CA, USA, 94404

Website

https://www.geron.com

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Geron Headlines

No Headlines